RetroSense to be honored at TechTown awards program for $60 million sale

13Oct

RetroSense to be honored at TechTown awards program for $60 million sale

Portfolio News

Sean Ainsworth, the CEO of Ann Arbor-based RetroSense Therapeutics LLC, will be honored as entrepreneur of the year Thursday night at TechTown Detroit’s annual Toast of the Town awards program. Read more >>

Share this post

Related Posts

10Jun

Sustained Acoustic Medicine Device sam® Offers an Alternative Solution to Pain Medication and Surgery

The advanced sustained acoustic medicine device (sam®) from ZetrOZ Systems offers physicians and orthopedic surgeons an alternative solution to pain... read more
05Feb

In Her Own Words: Covid propels Teresa Whalen to improve cancer treatment

As Omnicron continues to take a toll on the country, we’re reminded how many women are on the front lines... read more
23Jun

Myomo Resumes Fitting MyoPro Patients and Deliveries as States Begin to Re-Open after COVID-19 Shutdowns

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
27Jun

Wasabi Debuts U.S. West Coast New Data Center in Hillsboro, Oregon

Opens New Hot Cloud Storage Opportunities For US West Coast and Pac Rim Companies While Providing Direct Connection to One... read more
24Oct

Corbus Pharmaceuticals Announces Presentation of Data from its Phase 2b Study in Cystic Fibrosis at NACFC 2020

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the... read more
31May

District Ventures Capital Invests in Premama Wellness

District Ventures Capital (District Ventures) announced today it has closed an equity investment with Premama Wellness (Premama), producers of a... read more
13Jun

KnipBio Announces Significant Development in Lower-Cost Feedstock Solution for Aquafeed Protein

KnipBio, Inc. announced today a major development in its fermentation research that enables the company to produce its single cell... read more
07Nov

Siamab’s Antibody-drug Conjugates for Ovarian Cancer Seen to Succeed in Animal Models

Siamab Therapeutics’ preclinical work with anti-STn antibody-drug conjugates is moving forward, and in animal models — including primates — it... read more
23Jun

Founders who closed funding rounds this year share advice for raising capital

In this tough economic environment, venture capital funding can be difficult to find. In the U.S., startups’ total amount raised... read more
08Sep

Regroup Mass Notification Readies Temporary Network to Aid Organizations Affected by Hurricane Irma

Regroup Mass Notification announced that it is donating access to its powerful mass communication platform to organizations needing to communicate... read more